Global Artificial Intelligence in Pharma and Biotech Supply, Demand and Key Producers, 2026-2032
The global Artificial Intelligence in Pharma and Biotech market size is expected to reach $ 17923 million by 2032, rising at a market growth of 30.3% CAGR during the forecast period (2026-2032).
Artificial Intelligence in Pharma and Biotech refers to the application of artificial intelligence technologies in pharmaceutical, biotechnology, and life science research and commercialization processes. By utilizing technologies such as machine learning, deep learning, natural language processing (NLP), generative AI, computer vision, and knowledge graphs, AI systems analyze and process biomedical data, clinical information, molecular structures, and scientific literature to improve drug discovery efficiency, optimize clinical development, accelerate research and development processes, and reduce development costs. Key applications of AI in pharmaceutical and biotechnology industries include AI-driven drug discovery, target identification and validation, molecular design and optimization, protein structure prediction, clinical trial design and patient recruitment optimization, biomarker discovery, scientific literature analysis, and pharmaceutical manufacturing quality control. AI enables pharmaceutical and biotechnology companies to shorten drug development timelines, improve the accuracy of candidate drug screening, and accelerate advances in precision medicine, personalized therapies, and next-generation biopharmaceutical development.
This report is a detailed and comprehensive analysis of the world market for Artificial Intelligence in Pharma and Biotech, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Artificial Intelligence in Pharma and Biotech that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Artificial Intelligence in Pharma and Biotech market
2. What is the demand of the global Artificial Intelligence in Pharma and Biotech market?
3. What is the year over year growth of the global Artificial Intelligence in Pharma and Biotech market?
4. What is the total value of the global Artificial Intelligence in Pharma and Biotech market?
5. Who are the Major Players in the global Artificial Intelligence in Pharma and Biotech market?
6. What are the growth factors driving the market demand?
Artificial Intelligence in Pharma and Biotech refers to the application of artificial intelligence technologies in pharmaceutical, biotechnology, and life science research and commercialization processes. By utilizing technologies such as machine learning, deep learning, natural language processing (NLP), generative AI, computer vision, and knowledge graphs, AI systems analyze and process biomedical data, clinical information, molecular structures, and scientific literature to improve drug discovery efficiency, optimize clinical development, accelerate research and development processes, and reduce development costs. Key applications of AI in pharmaceutical and biotechnology industries include AI-driven drug discovery, target identification and validation, molecular design and optimization, protein structure prediction, clinical trial design and patient recruitment optimization, biomarker discovery, scientific literature analysis, and pharmaceutical manufacturing quality control. AI enables pharmaceutical and biotechnology companies to shorten drug development timelines, improve the accuracy of candidate drug screening, and accelerate advances in precision medicine, personalized therapies, and next-generation biopharmaceutical development.
Report Scope
This report studies the global Artificial Intelligence in Pharma and Biotech demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Artificial Intelligence in Pharma and Biotech, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Artificial Intelligence in Pharma and Biotech that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Artificial Intelligence in Pharma and Biotech total market, 2021-2032, (USD Million)
- Global Artificial Intelligence in Pharma and Biotech total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Artificial Intelligence in Pharma and Biotech total market, key domestic companies, and share, (USD Million)
- Global Artificial Intelligence in Pharma and Biotech revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Artificial Intelligence in Pharma and Biotech total market by Type, CAGR, 2021-2032, (USD Million)
- Global Artificial Intelligence in Pharma and Biotech total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Artificial Intelligence in Pharma and Biotech market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Artificial Intelligence in Pharma and Biotech Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Artificial Intelligence in Pharma and Biotech Market, Segmentation by Type:
- AI Drug Discovery
- Preclinical Research AI
- Clinical Trial AI
- Others
Global Artificial Intelligence in Pharma and Biotech Market, Segmentation by Technology:
- Machine Learning
- Deep Learning
- Generative AI
- Computer Vision
- Others
Global Artificial Intelligence in Pharma and Biotech Market, Segmentation by Application:
- Oncology
- Neurology
- Immunology
- Rare Diseases
- Infectious Diseases
- Others
Companies Profiled:
- AstraZeneca
- Thales Group
- IBM Corp.
- ForeSee Medical
- Atomwise
- Cloud Pharmaceuticals
- GNS Healthcare
- Microsoft Corporation
- Novartis AG
- NVIDIA Corporation
- Pfizer
- Recursion Pharmaceuticals
- XtalPi Inc
- Aidoc
- AliveCor
- GE Healthcare
- Imagen Technologies
- Vuno Inc.
- IDx Technologies Inc.
- Siemens Healthcare GmbH
- Neural Analytics
- Insilico Medicine
Key Questions Answered
1. How big is the global Artificial Intelligence in Pharma and Biotech market?2. What is the demand of the global Artificial Intelligence in Pharma and Biotech market?
3. What is the year over year growth of the global Artificial Intelligence in Pharma and Biotech market?
4. What is the total value of the global Artificial Intelligence in Pharma and Biotech market?
5. Who are the Major Players in the global Artificial Intelligence in Pharma and Biotech market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Artificial Intelligence in Pharma and Biotech Introduction
1.2 World Artificial Intelligence in Pharma and Biotech Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Artificial Intelligence in Pharma and Biotech Total Market by Region (by Headquarter Location)
1.3.1 World Artificial Intelligence in Pharma and Biotech Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032)
1.3.3 China Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032)
1.3.4 Europe Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032)
1.3.5 Japan Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032)
1.3.6 South Korea Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032)
1.3.7 ASEAN Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032)
1.3.8 India Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Artificial Intelligence in Pharma and Biotech Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
2.2 World Artificial Intelligence in Pharma and Biotech Consumption Value by Region
2.2.1 World Artificial Intelligence in Pharma and Biotech Consumption Value by Region (2021-2026)
2.2.2 World Artificial Intelligence in Pharma and Biotech Consumption Value Forecast by Region (2027-2032)
2.3 United States Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
2.4 China Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
2.5 Europe Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
2.6 Japan Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
2.7 South Korea Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
2.8 ASEAN Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
2.9 India Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
3 WORLD ARTIFICIAL INTELLIGENCE IN PHARMA AND BIOTECH COMPANIES COMPETITIVE ANALYSIS
3.1 World Artificial Intelligence in Pharma and Biotech Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Artificial Intelligence in Pharma and Biotech Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Artificial Intelligence in Pharma and Biotech in 2025
3.2.3 Global Concentration Ratios (CR8) for Artificial Intelligence in Pharma and Biotech in 2025
3.3 Artificial Intelligence in Pharma and Biotech Company Evaluation Quadrant
3.4 Artificial Intelligence in Pharma and Biotech Market: Overall Company Footprint Analysis
3.4.1 Artificial Intelligence in Pharma and Biotech Market: Region Footprint
3.4.2 Artificial Intelligence in Pharma and Biotech Market: Company Product Type Footprint
3.4.3 Artificial Intelligence in Pharma and Biotech Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Artificial Intelligence in Pharma and Biotech Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Artificial Intelligence in Pharma and Biotech Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Artificial Intelligence in Pharma and Biotech Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Artificial Intelligence in Pharma and Biotech Consumption Value Comparison
4.2.1 United States VS China: Artificial Intelligence in Pharma and Biotech Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Artificial Intelligence in Pharma and Biotech Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Artificial Intelligence in Pharma and Biotech Companies and Market Share, 2021-2026
4.3.1 United States Based Artificial Intelligence in Pharma and Biotech Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Artificial Intelligence in Pharma and Biotech Revenue, (2021-2026)
4.4 China Based Companies Artificial Intelligence in Pharma and Biotech Revenue and Market Share, 2021-2026
4.4.1 China Based Artificial Intelligence in Pharma and Biotech Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Artificial Intelligence in Pharma and Biotech Revenue, (2021-2026)
4.5 Rest of World Based Artificial Intelligence in Pharma and Biotech Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Artificial Intelligence in Pharma and Biotech Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Artificial Intelligence in Pharma and Biotech Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Artificial Intelligence in Pharma and Biotech Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 AI Drug Discovery
5.2.2 Preclinical Research AI
5.2.3 Clinical Trial AI
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Artificial Intelligence in Pharma and Biotech Market Size by Type (2021-2026)
5.3.2 World Artificial Intelligence in Pharma and Biotech Market Size by Type (2027-2032)
5.3.3 World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY
6.1 World Artificial Intelligence in Pharma and Biotech Market Size Overview by Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology
6.2.1 Machine Learning
6.2.2 Deep Learning
6.2.3 Generative AI
6.2.4 Computer Vision
6.2.5 Others
6.3 Market Segment by Technology
6.3.1 World Artificial Intelligence in Pharma and Biotech Market Size by Technology (2021-2026)
6.3.2 World Artificial Intelligence in Pharma and Biotech Market Size by Technology (2027-2032)
6.3.3 World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Technology (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Artificial Intelligence in Pharma and Biotech Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Oncology
7.2.2 Neurology
7.2.3 Immunology
7.2.4 Rare Diseases
7.2.5 Infectious Diseases
7.2.6 Others
7.3 Market Segment by Application
7.3.1 World Artificial Intelligence in Pharma and Biotech Market Size by Application (2021-2026)
7.3.2 World Artificial Intelligence in Pharma and Biotech Market Size by Application (2027-2032)
7.3.3 World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 AstraZeneca
8.1.1 AstraZeneca Details
8.1.2 AstraZeneca Major Business
8.1.3 AstraZeneca Artificial Intelligence in Pharma and Biotech Product and Services
8.1.4 AstraZeneca Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 AstraZeneca Recent Developments/Updates
8.1.6 AstraZeneca Competitive Strengths & Weaknesses
8.2 Thales Group
8.2.1 Thales Group Details
8.2.2 Thales Group Major Business
8.2.3 Thales Group Artificial Intelligence in Pharma and Biotech Product and Services
8.2.4 Thales Group Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Thales Group Recent Developments/Updates
8.2.6 Thales Group Competitive Strengths & Weaknesses
8.3 IBM Corp.
8.3.1 IBM Corp. Details
8.3.2 IBM Corp. Major Business
8.3.3 IBM Corp. Artificial Intelligence in Pharma and Biotech Product and Services
8.3.4 IBM Corp. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 IBM Corp. Recent Developments/Updates
8.3.6 IBM Corp. Competitive Strengths & Weaknesses
8.4 ForeSee Medical
8.4.1 ForeSee Medical Details
8.4.2 ForeSee Medical Major Business
8.4.3 ForeSee Medical Artificial Intelligence in Pharma and Biotech Product and Services
8.4.4 ForeSee Medical Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 ForeSee Medical Recent Developments/Updates
8.4.6 ForeSee Medical Competitive Strengths & Weaknesses
8.5 Atomwise
8.5.1 Atomwise Details
8.5.2 Atomwise Major Business
8.5.3 Atomwise Artificial Intelligence in Pharma and Biotech Product and Services
8.5.4 Atomwise Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Atomwise Recent Developments/Updates
8.5.6 Atomwise Competitive Strengths & Weaknesses
8.6 Cloud Pharmaceuticals
8.6.1 Cloud Pharmaceuticals Details
8.6.2 Cloud Pharmaceuticals Major Business
8.6.3 Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Services
8.6.4 Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Cloud Pharmaceuticals Recent Developments/Updates
8.6.6 Cloud Pharmaceuticals Competitive Strengths & Weaknesses
8.7 GNS Healthcare
8.7.1 GNS Healthcare Details
8.7.2 GNS Healthcare Major Business
8.7.3 GNS Healthcare Artificial Intelligence in Pharma and Biotech Product and Services
8.7.4 GNS Healthcare Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 GNS Healthcare Recent Developments/Updates
8.7.6 GNS Healthcare Competitive Strengths & Weaknesses
8.8 Microsoft Corporation
8.8.1 Microsoft Corporation Details
8.8.2 Microsoft Corporation Major Business
8.8.3 Microsoft Corporation Artificial Intelligence in Pharma and Biotech Product and Services
8.8.4 Microsoft Corporation Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Microsoft Corporation Recent Developments/Updates
8.8.6 Microsoft Corporation Competitive Strengths & Weaknesses
8.9 Novartis AG
8.9.1 Novartis AG Details
8.9.2 Novartis AG Major Business
8.9.3 Novartis AG Artificial Intelligence in Pharma and Biotech Product and Services
8.9.4 Novartis AG Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 Novartis AG Recent Developments/Updates
8.9.6 Novartis AG Competitive Strengths & Weaknesses
8.10 NVIDIA Corporation
8.10.1 NVIDIA Corporation Details
8.10.2 NVIDIA Corporation Major Business
8.10.3 NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Product and Services
8.10.4 NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 NVIDIA Corporation Recent Developments/Updates
8.10.6 NVIDIA Corporation Competitive Strengths & Weaknesses
8.11 Pfizer
8.11.1 Pfizer Details
8.11.2 Pfizer Major Business
8.11.3 Pfizer Artificial Intelligence in Pharma and Biotech Product and Services
8.11.4 Pfizer Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 Pfizer Recent Developments/Updates
8.11.6 Pfizer Competitive Strengths & Weaknesses
8.12 Recursion Pharmaceuticals
8.12.1 Recursion Pharmaceuticals Details
8.12.2 Recursion Pharmaceuticals Major Business
8.12.3 Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Services
8.12.4 Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 Recursion Pharmaceuticals Recent Developments/Updates
8.12.6 Recursion Pharmaceuticals Competitive Strengths & Weaknesses
8.13 XtalPi Inc
8.13.1 XtalPi Inc Details
8.13.2 XtalPi Inc Major Business
8.13.3 XtalPi Inc Artificial Intelligence in Pharma and Biotech Product and Services
8.13.4 XtalPi Inc Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 XtalPi Inc Recent Developments/Updates
8.13.6 XtalPi Inc Competitive Strengths & Weaknesses
8.14 Aidoc
8.14.1 Aidoc Details
8.14.2 Aidoc Major Business
8.14.3 Aidoc Artificial Intelligence in Pharma and Biotech Product and Services
8.14.4 Aidoc Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.14.5 Aidoc Recent Developments/Updates
8.14.6 Aidoc Competitive Strengths & Weaknesses
8.15 AliveCor
8.15.1 AliveCor Details
8.15.2 AliveCor Major Business
8.15.3 AliveCor Artificial Intelligence in Pharma and Biotech Product and Services
8.15.4 AliveCor Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.15.5 AliveCor Recent Developments/Updates
8.15.6 AliveCor Competitive Strengths & Weaknesses
8.16 GE Healthcare
8.16.1 GE Healthcare Details
8.16.2 GE Healthcare Major Business
8.16.3 GE Healthcare Artificial Intelligence in Pharma and Biotech Product and Services
8.16.4 GE Healthcare Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.16.5 GE Healthcare Recent Developments/Updates
8.16.6 GE Healthcare Competitive Strengths & Weaknesses
8.17 Imagen Technologies
8.17.1 Imagen Technologies Details
8.17.2 Imagen Technologies Major Business
8.17.3 Imagen Technologies Artificial Intelligence in Pharma and Biotech Product and Services
8.17.4 Imagen Technologies Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.17.5 Imagen Technologies Recent Developments/Updates
8.17.6 Imagen Technologies Competitive Strengths & Weaknesses
8.18 Vuno Inc.
8.18.1 Vuno Inc. Details
8.18.2 Vuno Inc. Major Business
8.18.3 Vuno Inc. Artificial Intelligence in Pharma and Biotech Product and Services
8.18.4 Vuno Inc. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.18.5 Vuno Inc. Recent Developments/Updates
8.18.6 Vuno Inc. Competitive Strengths & Weaknesses
8.19 IDx Technologies Inc.
8.19.1 IDx Technologies Inc. Details
8.19.2 IDx Technologies Inc. Major Business
8.19.3 IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Product and Services
8.19.4 IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.19.5 IDx Technologies Inc. Recent Developments/Updates
8.19.6 IDx Technologies Inc. Competitive Strengths & Weaknesses
8.20 Siemens Healthcare GmbH
8.20.1 Siemens Healthcare GmbH Details
8.20.2 Siemens Healthcare GmbH Major Business
8.20.3 Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Product and Services
8.20.4 Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.20.5 Siemens Healthcare GmbH Recent Developments/Updates
8.20.6 Siemens Healthcare GmbH Competitive Strengths & Weaknesses
8.21 Neural Analytics
8.21.1 Neural Analytics Details
8.21.2 Neural Analytics Major Business
8.21.3 Neural Analytics Artificial Intelligence in Pharma and Biotech Product and Services
8.21.4 Neural Analytics Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.21.5 Neural Analytics Recent Developments/Updates
8.21.6 Neural Analytics Competitive Strengths & Weaknesses
8.22 Insilico Medicine
8.22.1 Insilico Medicine Details
8.22.2 Insilico Medicine Major Business
8.22.3 Insilico Medicine Artificial Intelligence in Pharma and Biotech Product and Services
8.22.4 Insilico Medicine Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.22.5 Insilico Medicine Recent Developments/Updates
8.22.6 Insilico Medicine Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Artificial Intelligence in Pharma and Biotech Industry Chain
9.2 Artificial Intelligence in Pharma and Biotech Upstream Analysis
9.3 Artificial Intelligence in Pharma and Biotech Midstream Analysis
9.4 Artificial Intelligence in Pharma and Biotech Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Artificial Intelligence in Pharma and Biotech Introduction
1.2 World Artificial Intelligence in Pharma and Biotech Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Artificial Intelligence in Pharma and Biotech Total Market by Region (by Headquarter Location)
1.3.1 World Artificial Intelligence in Pharma and Biotech Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032)
1.3.3 China Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032)
1.3.4 Europe Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032)
1.3.5 Japan Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032)
1.3.6 South Korea Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032)
1.3.7 ASEAN Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032)
1.3.8 India Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Artificial Intelligence in Pharma and Biotech Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
2.2 World Artificial Intelligence in Pharma and Biotech Consumption Value by Region
2.2.1 World Artificial Intelligence in Pharma and Biotech Consumption Value by Region (2021-2026)
2.2.2 World Artificial Intelligence in Pharma and Biotech Consumption Value Forecast by Region (2027-2032)
2.3 United States Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
2.4 China Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
2.5 Europe Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
2.6 Japan Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
2.7 South Korea Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
2.8 ASEAN Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
2.9 India Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032)
3 WORLD ARTIFICIAL INTELLIGENCE IN PHARMA AND BIOTECH COMPANIES COMPETITIVE ANALYSIS
3.1 World Artificial Intelligence in Pharma and Biotech Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Artificial Intelligence in Pharma and Biotech Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Artificial Intelligence in Pharma and Biotech in 2025
3.2.3 Global Concentration Ratios (CR8) for Artificial Intelligence in Pharma and Biotech in 2025
3.3 Artificial Intelligence in Pharma and Biotech Company Evaluation Quadrant
3.4 Artificial Intelligence in Pharma and Biotech Market: Overall Company Footprint Analysis
3.4.1 Artificial Intelligence in Pharma and Biotech Market: Region Footprint
3.4.2 Artificial Intelligence in Pharma and Biotech Market: Company Product Type Footprint
3.4.3 Artificial Intelligence in Pharma and Biotech Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Artificial Intelligence in Pharma and Biotech Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Artificial Intelligence in Pharma and Biotech Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Artificial Intelligence in Pharma and Biotech Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Artificial Intelligence in Pharma and Biotech Consumption Value Comparison
4.2.1 United States VS China: Artificial Intelligence in Pharma and Biotech Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Artificial Intelligence in Pharma and Biotech Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Artificial Intelligence in Pharma and Biotech Companies and Market Share, 2021-2026
4.3.1 United States Based Artificial Intelligence in Pharma and Biotech Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Artificial Intelligence in Pharma and Biotech Revenue, (2021-2026)
4.4 China Based Companies Artificial Intelligence in Pharma and Biotech Revenue and Market Share, 2021-2026
4.4.1 China Based Artificial Intelligence in Pharma and Biotech Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Artificial Intelligence in Pharma and Biotech Revenue, (2021-2026)
4.5 Rest of World Based Artificial Intelligence in Pharma and Biotech Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Artificial Intelligence in Pharma and Biotech Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Artificial Intelligence in Pharma and Biotech Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Artificial Intelligence in Pharma and Biotech Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 AI Drug Discovery
5.2.2 Preclinical Research AI
5.2.3 Clinical Trial AI
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Artificial Intelligence in Pharma and Biotech Market Size by Type (2021-2026)
5.3.2 World Artificial Intelligence in Pharma and Biotech Market Size by Type (2027-2032)
5.3.3 World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY
6.1 World Artificial Intelligence in Pharma and Biotech Market Size Overview by Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology
6.2.1 Machine Learning
6.2.2 Deep Learning
6.2.3 Generative AI
6.2.4 Computer Vision
6.2.5 Others
6.3 Market Segment by Technology
6.3.1 World Artificial Intelligence in Pharma and Biotech Market Size by Technology (2021-2026)
6.3.2 World Artificial Intelligence in Pharma and Biotech Market Size by Technology (2027-2032)
6.3.3 World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Technology (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Artificial Intelligence in Pharma and Biotech Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Oncology
7.2.2 Neurology
7.2.3 Immunology
7.2.4 Rare Diseases
7.2.5 Infectious Diseases
7.2.6 Others
7.3 Market Segment by Application
7.3.1 World Artificial Intelligence in Pharma and Biotech Market Size by Application (2021-2026)
7.3.2 World Artificial Intelligence in Pharma and Biotech Market Size by Application (2027-2032)
7.3.3 World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 AstraZeneca
8.1.1 AstraZeneca Details
8.1.2 AstraZeneca Major Business
8.1.3 AstraZeneca Artificial Intelligence in Pharma and Biotech Product and Services
8.1.4 AstraZeneca Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 AstraZeneca Recent Developments/Updates
8.1.6 AstraZeneca Competitive Strengths & Weaknesses
8.2 Thales Group
8.2.1 Thales Group Details
8.2.2 Thales Group Major Business
8.2.3 Thales Group Artificial Intelligence in Pharma and Biotech Product and Services
8.2.4 Thales Group Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Thales Group Recent Developments/Updates
8.2.6 Thales Group Competitive Strengths & Weaknesses
8.3 IBM Corp.
8.3.1 IBM Corp. Details
8.3.2 IBM Corp. Major Business
8.3.3 IBM Corp. Artificial Intelligence in Pharma and Biotech Product and Services
8.3.4 IBM Corp. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 IBM Corp. Recent Developments/Updates
8.3.6 IBM Corp. Competitive Strengths & Weaknesses
8.4 ForeSee Medical
8.4.1 ForeSee Medical Details
8.4.2 ForeSee Medical Major Business
8.4.3 ForeSee Medical Artificial Intelligence in Pharma and Biotech Product and Services
8.4.4 ForeSee Medical Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 ForeSee Medical Recent Developments/Updates
8.4.6 ForeSee Medical Competitive Strengths & Weaknesses
8.5 Atomwise
8.5.1 Atomwise Details
8.5.2 Atomwise Major Business
8.5.3 Atomwise Artificial Intelligence in Pharma and Biotech Product and Services
8.5.4 Atomwise Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Atomwise Recent Developments/Updates
8.5.6 Atomwise Competitive Strengths & Weaknesses
8.6 Cloud Pharmaceuticals
8.6.1 Cloud Pharmaceuticals Details
8.6.2 Cloud Pharmaceuticals Major Business
8.6.3 Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Services
8.6.4 Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Cloud Pharmaceuticals Recent Developments/Updates
8.6.6 Cloud Pharmaceuticals Competitive Strengths & Weaknesses
8.7 GNS Healthcare
8.7.1 GNS Healthcare Details
8.7.2 GNS Healthcare Major Business
8.7.3 GNS Healthcare Artificial Intelligence in Pharma and Biotech Product and Services
8.7.4 GNS Healthcare Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 GNS Healthcare Recent Developments/Updates
8.7.6 GNS Healthcare Competitive Strengths & Weaknesses
8.8 Microsoft Corporation
8.8.1 Microsoft Corporation Details
8.8.2 Microsoft Corporation Major Business
8.8.3 Microsoft Corporation Artificial Intelligence in Pharma and Biotech Product and Services
8.8.4 Microsoft Corporation Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Microsoft Corporation Recent Developments/Updates
8.8.6 Microsoft Corporation Competitive Strengths & Weaknesses
8.9 Novartis AG
8.9.1 Novartis AG Details
8.9.2 Novartis AG Major Business
8.9.3 Novartis AG Artificial Intelligence in Pharma and Biotech Product and Services
8.9.4 Novartis AG Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 Novartis AG Recent Developments/Updates
8.9.6 Novartis AG Competitive Strengths & Weaknesses
8.10 NVIDIA Corporation
8.10.1 NVIDIA Corporation Details
8.10.2 NVIDIA Corporation Major Business
8.10.3 NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Product and Services
8.10.4 NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 NVIDIA Corporation Recent Developments/Updates
8.10.6 NVIDIA Corporation Competitive Strengths & Weaknesses
8.11 Pfizer
8.11.1 Pfizer Details
8.11.2 Pfizer Major Business
8.11.3 Pfizer Artificial Intelligence in Pharma and Biotech Product and Services
8.11.4 Pfizer Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 Pfizer Recent Developments/Updates
8.11.6 Pfizer Competitive Strengths & Weaknesses
8.12 Recursion Pharmaceuticals
8.12.1 Recursion Pharmaceuticals Details
8.12.2 Recursion Pharmaceuticals Major Business
8.12.3 Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Services
8.12.4 Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 Recursion Pharmaceuticals Recent Developments/Updates
8.12.6 Recursion Pharmaceuticals Competitive Strengths & Weaknesses
8.13 XtalPi Inc
8.13.1 XtalPi Inc Details
8.13.2 XtalPi Inc Major Business
8.13.3 XtalPi Inc Artificial Intelligence in Pharma and Biotech Product and Services
8.13.4 XtalPi Inc Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 XtalPi Inc Recent Developments/Updates
8.13.6 XtalPi Inc Competitive Strengths & Weaknesses
8.14 Aidoc
8.14.1 Aidoc Details
8.14.2 Aidoc Major Business
8.14.3 Aidoc Artificial Intelligence in Pharma and Biotech Product and Services
8.14.4 Aidoc Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.14.5 Aidoc Recent Developments/Updates
8.14.6 Aidoc Competitive Strengths & Weaknesses
8.15 AliveCor
8.15.1 AliveCor Details
8.15.2 AliveCor Major Business
8.15.3 AliveCor Artificial Intelligence in Pharma and Biotech Product and Services
8.15.4 AliveCor Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.15.5 AliveCor Recent Developments/Updates
8.15.6 AliveCor Competitive Strengths & Weaknesses
8.16 GE Healthcare
8.16.1 GE Healthcare Details
8.16.2 GE Healthcare Major Business
8.16.3 GE Healthcare Artificial Intelligence in Pharma and Biotech Product and Services
8.16.4 GE Healthcare Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.16.5 GE Healthcare Recent Developments/Updates
8.16.6 GE Healthcare Competitive Strengths & Weaknesses
8.17 Imagen Technologies
8.17.1 Imagen Technologies Details
8.17.2 Imagen Technologies Major Business
8.17.3 Imagen Technologies Artificial Intelligence in Pharma and Biotech Product and Services
8.17.4 Imagen Technologies Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.17.5 Imagen Technologies Recent Developments/Updates
8.17.6 Imagen Technologies Competitive Strengths & Weaknesses
8.18 Vuno Inc.
8.18.1 Vuno Inc. Details
8.18.2 Vuno Inc. Major Business
8.18.3 Vuno Inc. Artificial Intelligence in Pharma and Biotech Product and Services
8.18.4 Vuno Inc. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.18.5 Vuno Inc. Recent Developments/Updates
8.18.6 Vuno Inc. Competitive Strengths & Weaknesses
8.19 IDx Technologies Inc.
8.19.1 IDx Technologies Inc. Details
8.19.2 IDx Technologies Inc. Major Business
8.19.3 IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Product and Services
8.19.4 IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.19.5 IDx Technologies Inc. Recent Developments/Updates
8.19.6 IDx Technologies Inc. Competitive Strengths & Weaknesses
8.20 Siemens Healthcare GmbH
8.20.1 Siemens Healthcare GmbH Details
8.20.2 Siemens Healthcare GmbH Major Business
8.20.3 Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Product and Services
8.20.4 Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.20.5 Siemens Healthcare GmbH Recent Developments/Updates
8.20.6 Siemens Healthcare GmbH Competitive Strengths & Weaknesses
8.21 Neural Analytics
8.21.1 Neural Analytics Details
8.21.2 Neural Analytics Major Business
8.21.3 Neural Analytics Artificial Intelligence in Pharma and Biotech Product and Services
8.21.4 Neural Analytics Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.21.5 Neural Analytics Recent Developments/Updates
8.21.6 Neural Analytics Competitive Strengths & Weaknesses
8.22 Insilico Medicine
8.22.1 Insilico Medicine Details
8.22.2 Insilico Medicine Major Business
8.22.3 Insilico Medicine Artificial Intelligence in Pharma and Biotech Product and Services
8.22.4 Insilico Medicine Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
8.22.5 Insilico Medicine Recent Developments/Updates
8.22.6 Insilico Medicine Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Artificial Intelligence in Pharma and Biotech Industry Chain
9.2 Artificial Intelligence in Pharma and Biotech Upstream Analysis
9.3 Artificial Intelligence in Pharma and Biotech Midstream Analysis
9.4 Artificial Intelligence in Pharma and Biotech Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Artificial Intelligence in Pharma and Biotech Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Artificial Intelligence in Pharma and Biotech Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Artificial Intelligence in Pharma and Biotech Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Artificial Intelligence in Pharma and Biotech Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Artificial Intelligence in Pharma and Biotech Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Artificial Intelligence in Pharma and Biotech Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Artificial Intelligence in Pharma and Biotech Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Artificial Intelligence in Pharma and Biotech Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Artificial Intelligence in Pharma and Biotech Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Artificial Intelligence in Pharma and Biotech Players in 2025
Table 12. World Artificial Intelligence in Pharma and Biotech Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Artificial Intelligence in Pharma and Biotech Company Evaluation Quadrant
Table 14. Head Office of Key Artificial Intelligence in Pharma and Biotech Players
Table 15. Artificial Intelligence in Pharma and Biotech Market: Company Product Type Footprint
Table 16. Artificial Intelligence in Pharma and Biotech Market: Company Product Application Footprint
Table 17. Artificial Intelligence in Pharma and Biotech Mergers & Acquisitions Activity
Table 18. United States VS China Artificial Intelligence in Pharma and Biotech Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Artificial Intelligence in Pharma and Biotech Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Artificial Intelligence in Pharma and Biotech Companies, Headquarters (States, Country)
Table 21. United States Based Companies Artificial Intelligence in Pharma and Biotech Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Artificial Intelligence in Pharma and Biotech Revenue Market Share (2021-2026)
Table 23. China Based Artificial Intelligence in Pharma and Biotech Companies, Headquarters (Province, Country)
Table 24. China Based Companies Artificial Intelligence in Pharma and Biotech Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Artificial Intelligence in Pharma and Biotech Revenue Market Share (2021-2026)
Table 26. Rest of World Based Artificial Intelligence in Pharma and Biotech Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Artificial Intelligence in Pharma and Biotech Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Artificial Intelligence in Pharma and Biotech Revenue Market Share (2021-2026)
Table 29. World Artificial Intelligence in Pharma and Biotech Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Artificial Intelligence in Pharma and Biotech Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Artificial Intelligence in Pharma and Biotech Market Size by Type (2027-2032) & (USD Million)
Table 32. World Artificial Intelligence in Pharma and Biotech Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Table 33. World Artificial Intelligence in Pharma and Biotech Market Size Value by Technology (2021-2026) & (USD Million)
Table 34. World Artificial Intelligence in Pharma and Biotech Market Size by Technology (2027-2032) & (USD Million)
Table 35. World Artificial Intelligence in Pharma and Biotech Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Artificial Intelligence in Pharma and Biotech Market Size by Application (2021-2026) & (USD Million)
Table 37. World Artificial Intelligence in Pharma and Biotech Market Size by Application (2027-2032) & (USD Million)
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Major Business
Table 40. AstraZeneca Artificial Intelligence in Pharma and Biotech Product and Services
Table 41. AstraZeneca Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. AstraZeneca Recent Developments/Updates
Table 43. AstraZeneca Competitive Strengths & Weaknesses
Table 44. Thales Group Basic Information, Manufacturing Base and Competitors
Table 45. Thales Group Major Business
Table 46. Thales Group Artificial Intelligence in Pharma and Biotech Product and Services
Table 47. Thales Group Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Thales Group Recent Developments/Updates
Table 49. Thales Group Competitive Strengths & Weaknesses
Table 50. IBM Corp. Basic Information, Manufacturing Base and Competitors
Table 51. IBM Corp. Major Business
Table 52. IBM Corp. Artificial Intelligence in Pharma and Biotech Product and Services
Table 53. IBM Corp. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. IBM Corp. Recent Developments/Updates
Table 55. IBM Corp. Competitive Strengths & Weaknesses
Table 56. ForeSee Medical Basic Information, Manufacturing Base and Competitors
Table 57. ForeSee Medical Major Business
Table 58. ForeSee Medical Artificial Intelligence in Pharma and Biotech Product and Services
Table 59. ForeSee Medical Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. ForeSee Medical Recent Developments/Updates
Table 61. ForeSee Medical Competitive Strengths & Weaknesses
Table 62. Atomwise Basic Information, Manufacturing Base and Competitors
Table 63. Atomwise Major Business
Table 64. Atomwise Artificial Intelligence in Pharma and Biotech Product and Services
Table 65. Atomwise Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Atomwise Recent Developments/Updates
Table 67. Atomwise Competitive Strengths & Weaknesses
Table 68. Cloud Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 69. Cloud Pharmaceuticals Major Business
Table 70. Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Services
Table 71. Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Cloud Pharmaceuticals Recent Developments/Updates
Table 73. Cloud Pharmaceuticals Competitive Strengths & Weaknesses
Table 74. GNS Healthcare Basic Information, Manufacturing Base and Competitors
Table 75. GNS Healthcare Major Business
Table 76. GNS Healthcare Artificial Intelligence in Pharma and Biotech Product and Services
Table 77. GNS Healthcare Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. GNS Healthcare Recent Developments/Updates
Table 79. GNS Healthcare Competitive Strengths & Weaknesses
Table 80. Microsoft Corporation Basic Information, Manufacturing Base and Competitors
Table 81. Microsoft Corporation Major Business
Table 82. Microsoft Corporation Artificial Intelligence in Pharma and Biotech Product and Services
Table 83. Microsoft Corporation Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Microsoft Corporation Recent Developments/Updates
Table 85. Microsoft Corporation Competitive Strengths & Weaknesses
Table 86. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 87. Novartis AG Major Business
Table 88. Novartis AG Artificial Intelligence in Pharma and Biotech Product and Services
Table 89. Novartis AG Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Novartis AG Recent Developments/Updates
Table 91. Novartis AG Competitive Strengths & Weaknesses
Table 92. NVIDIA Corporation Basic Information, Manufacturing Base and Competitors
Table 93. NVIDIA Corporation Major Business
Table 94. NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Product and Services
Table 95. NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. NVIDIA Corporation Recent Developments/Updates
Table 97. NVIDIA Corporation Competitive Strengths & Weaknesses
Table 98. Pfizer Basic Information, Manufacturing Base and Competitors
Table 99. Pfizer Major Business
Table 100. Pfizer Artificial Intelligence in Pharma and Biotech Product and Services
Table 101. Pfizer Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Pfizer Recent Developments/Updates
Table 103. Pfizer Competitive Strengths & Weaknesses
Table 104. Recursion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 105. Recursion Pharmaceuticals Major Business
Table 106. Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Services
Table 107. Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Recursion Pharmaceuticals Recent Developments/Updates
Table 109. Recursion Pharmaceuticals Competitive Strengths & Weaknesses
Table 110. XtalPi Inc Basic Information, Manufacturing Base and Competitors
Table 111. XtalPi Inc Major Business
Table 112. XtalPi Inc Artificial Intelligence in Pharma and Biotech Product and Services
Table 113. XtalPi Inc Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. XtalPi Inc Recent Developments/Updates
Table 115. XtalPi Inc Competitive Strengths & Weaknesses
Table 116. Aidoc Basic Information, Manufacturing Base and Competitors
Table 117. Aidoc Major Business
Table 118. Aidoc Artificial Intelligence in Pharma and Biotech Product and Services
Table 119. Aidoc Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Aidoc Recent Developments/Updates
Table 121. Aidoc Competitive Strengths & Weaknesses
Table 122. AliveCor Basic Information, Manufacturing Base and Competitors
Table 123. AliveCor Major Business
Table 124. AliveCor Artificial Intelligence in Pharma and Biotech Product and Services
Table 125. AliveCor Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. AliveCor Recent Developments/Updates
Table 127. AliveCor Competitive Strengths & Weaknesses
Table 128. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 129. GE Healthcare Major Business
Table 130. GE Healthcare Artificial Intelligence in Pharma and Biotech Product and Services
Table 131. GE Healthcare Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. GE Healthcare Recent Developments/Updates
Table 133. GE Healthcare Competitive Strengths & Weaknesses
Table 134. Imagen Technologies Basic Information, Manufacturing Base and Competitors
Table 135. Imagen Technologies Major Business
Table 136. Imagen Technologies Artificial Intelligence in Pharma and Biotech Product and Services
Table 137. Imagen Technologies Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Imagen Technologies Recent Developments/Updates
Table 139. Imagen Technologies Competitive Strengths & Weaknesses
Table 140. Vuno Inc. Basic Information, Manufacturing Base and Competitors
Table 141. Vuno Inc. Major Business
Table 142. Vuno Inc. Artificial Intelligence in Pharma and Biotech Product and Services
Table 143. Vuno Inc. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. Vuno Inc. Recent Developments/Updates
Table 145. Vuno Inc. Competitive Strengths & Weaknesses
Table 146. IDx Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table 147. IDx Technologies Inc. Major Business
Table 148. IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Product and Services
Table 149. IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 150. IDx Technologies Inc. Recent Developments/Updates
Table 151. IDx Technologies Inc. Competitive Strengths & Weaknesses
Table 152. Siemens Healthcare GmbH Basic Information, Manufacturing Base and Competitors
Table 153. Siemens Healthcare GmbH Major Business
Table 154. Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Product and Services
Table 155. Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 156. Siemens Healthcare GmbH Recent Developments/Updates
Table 157. Siemens Healthcare GmbH Competitive Strengths & Weaknesses
Table 158. Neural Analytics Basic Information, Manufacturing Base and Competitors
Table 159. Neural Analytics Major Business
Table 160. Neural Analytics Artificial Intelligence in Pharma and Biotech Product and Services
Table 161. Neural Analytics Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 162. Neural Analytics Recent Developments/Updates
Table 163. Neural Analytics Competitive Strengths & Weaknesses
Table 164. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 165. Insilico Medicine Major Business
Table 166. Insilico Medicine Artificial Intelligence in Pharma and Biotech Product and Services
Table 167. Insilico Medicine Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 168. Insilico Medicine Recent Developments/Updates
Table 169. Insilico Medicine Competitive Strengths & Weaknesses
Table 170. Global Key Players of Artificial Intelligence in Pharma and Biotech Upstream (Raw Materials)
Table 171. Global Artificial Intelligence in Pharma and Biotech Typical Customers
Table 1. World Artificial Intelligence in Pharma and Biotech Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Artificial Intelligence in Pharma and Biotech Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Artificial Intelligence in Pharma and Biotech Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Artificial Intelligence in Pharma and Biotech Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Artificial Intelligence in Pharma and Biotech Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Artificial Intelligence in Pharma and Biotech Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Artificial Intelligence in Pharma and Biotech Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Artificial Intelligence in Pharma and Biotech Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Artificial Intelligence in Pharma and Biotech Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Artificial Intelligence in Pharma and Biotech Players in 2025
Table 12. World Artificial Intelligence in Pharma and Biotech Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Artificial Intelligence in Pharma and Biotech Company Evaluation Quadrant
Table 14. Head Office of Key Artificial Intelligence in Pharma and Biotech Players
Table 15. Artificial Intelligence in Pharma and Biotech Market: Company Product Type Footprint
Table 16. Artificial Intelligence in Pharma and Biotech Market: Company Product Application Footprint
Table 17. Artificial Intelligence in Pharma and Biotech Mergers & Acquisitions Activity
Table 18. United States VS China Artificial Intelligence in Pharma and Biotech Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Artificial Intelligence in Pharma and Biotech Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Artificial Intelligence in Pharma and Biotech Companies, Headquarters (States, Country)
Table 21. United States Based Companies Artificial Intelligence in Pharma and Biotech Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Artificial Intelligence in Pharma and Biotech Revenue Market Share (2021-2026)
Table 23. China Based Artificial Intelligence in Pharma and Biotech Companies, Headquarters (Province, Country)
Table 24. China Based Companies Artificial Intelligence in Pharma and Biotech Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Artificial Intelligence in Pharma and Biotech Revenue Market Share (2021-2026)
Table 26. Rest of World Based Artificial Intelligence in Pharma and Biotech Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Artificial Intelligence in Pharma and Biotech Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Artificial Intelligence in Pharma and Biotech Revenue Market Share (2021-2026)
Table 29. World Artificial Intelligence in Pharma and Biotech Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Artificial Intelligence in Pharma and Biotech Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Artificial Intelligence in Pharma and Biotech Market Size by Type (2027-2032) & (USD Million)
Table 32. World Artificial Intelligence in Pharma and Biotech Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Table 33. World Artificial Intelligence in Pharma and Biotech Market Size Value by Technology (2021-2026) & (USD Million)
Table 34. World Artificial Intelligence in Pharma and Biotech Market Size by Technology (2027-2032) & (USD Million)
Table 35. World Artificial Intelligence in Pharma and Biotech Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Artificial Intelligence in Pharma and Biotech Market Size by Application (2021-2026) & (USD Million)
Table 37. World Artificial Intelligence in Pharma and Biotech Market Size by Application (2027-2032) & (USD Million)
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Major Business
Table 40. AstraZeneca Artificial Intelligence in Pharma and Biotech Product and Services
Table 41. AstraZeneca Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. AstraZeneca Recent Developments/Updates
Table 43. AstraZeneca Competitive Strengths & Weaknesses
Table 44. Thales Group Basic Information, Manufacturing Base and Competitors
Table 45. Thales Group Major Business
Table 46. Thales Group Artificial Intelligence in Pharma and Biotech Product and Services
Table 47. Thales Group Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Thales Group Recent Developments/Updates
Table 49. Thales Group Competitive Strengths & Weaknesses
Table 50. IBM Corp. Basic Information, Manufacturing Base and Competitors
Table 51. IBM Corp. Major Business
Table 52. IBM Corp. Artificial Intelligence in Pharma and Biotech Product and Services
Table 53. IBM Corp. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. IBM Corp. Recent Developments/Updates
Table 55. IBM Corp. Competitive Strengths & Weaknesses
Table 56. ForeSee Medical Basic Information, Manufacturing Base and Competitors
Table 57. ForeSee Medical Major Business
Table 58. ForeSee Medical Artificial Intelligence in Pharma and Biotech Product and Services
Table 59. ForeSee Medical Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. ForeSee Medical Recent Developments/Updates
Table 61. ForeSee Medical Competitive Strengths & Weaknesses
Table 62. Atomwise Basic Information, Manufacturing Base and Competitors
Table 63. Atomwise Major Business
Table 64. Atomwise Artificial Intelligence in Pharma and Biotech Product and Services
Table 65. Atomwise Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Atomwise Recent Developments/Updates
Table 67. Atomwise Competitive Strengths & Weaknesses
Table 68. Cloud Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 69. Cloud Pharmaceuticals Major Business
Table 70. Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Services
Table 71. Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Cloud Pharmaceuticals Recent Developments/Updates
Table 73. Cloud Pharmaceuticals Competitive Strengths & Weaknesses
Table 74. GNS Healthcare Basic Information, Manufacturing Base and Competitors
Table 75. GNS Healthcare Major Business
Table 76. GNS Healthcare Artificial Intelligence in Pharma and Biotech Product and Services
Table 77. GNS Healthcare Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. GNS Healthcare Recent Developments/Updates
Table 79. GNS Healthcare Competitive Strengths & Weaknesses
Table 80. Microsoft Corporation Basic Information, Manufacturing Base and Competitors
Table 81. Microsoft Corporation Major Business
Table 82. Microsoft Corporation Artificial Intelligence in Pharma and Biotech Product and Services
Table 83. Microsoft Corporation Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Microsoft Corporation Recent Developments/Updates
Table 85. Microsoft Corporation Competitive Strengths & Weaknesses
Table 86. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 87. Novartis AG Major Business
Table 88. Novartis AG Artificial Intelligence in Pharma and Biotech Product and Services
Table 89. Novartis AG Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Novartis AG Recent Developments/Updates
Table 91. Novartis AG Competitive Strengths & Weaknesses
Table 92. NVIDIA Corporation Basic Information, Manufacturing Base and Competitors
Table 93. NVIDIA Corporation Major Business
Table 94. NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Product and Services
Table 95. NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. NVIDIA Corporation Recent Developments/Updates
Table 97. NVIDIA Corporation Competitive Strengths & Weaknesses
Table 98. Pfizer Basic Information, Manufacturing Base and Competitors
Table 99. Pfizer Major Business
Table 100. Pfizer Artificial Intelligence in Pharma and Biotech Product and Services
Table 101. Pfizer Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Pfizer Recent Developments/Updates
Table 103. Pfizer Competitive Strengths & Weaknesses
Table 104. Recursion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 105. Recursion Pharmaceuticals Major Business
Table 106. Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Services
Table 107. Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Recursion Pharmaceuticals Recent Developments/Updates
Table 109. Recursion Pharmaceuticals Competitive Strengths & Weaknesses
Table 110. XtalPi Inc Basic Information, Manufacturing Base and Competitors
Table 111. XtalPi Inc Major Business
Table 112. XtalPi Inc Artificial Intelligence in Pharma and Biotech Product and Services
Table 113. XtalPi Inc Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. XtalPi Inc Recent Developments/Updates
Table 115. XtalPi Inc Competitive Strengths & Weaknesses
Table 116. Aidoc Basic Information, Manufacturing Base and Competitors
Table 117. Aidoc Major Business
Table 118. Aidoc Artificial Intelligence in Pharma and Biotech Product and Services
Table 119. Aidoc Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Aidoc Recent Developments/Updates
Table 121. Aidoc Competitive Strengths & Weaknesses
Table 122. AliveCor Basic Information, Manufacturing Base and Competitors
Table 123. AliveCor Major Business
Table 124. AliveCor Artificial Intelligence in Pharma and Biotech Product and Services
Table 125. AliveCor Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. AliveCor Recent Developments/Updates
Table 127. AliveCor Competitive Strengths & Weaknesses
Table 128. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 129. GE Healthcare Major Business
Table 130. GE Healthcare Artificial Intelligence in Pharma and Biotech Product and Services
Table 131. GE Healthcare Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. GE Healthcare Recent Developments/Updates
Table 133. GE Healthcare Competitive Strengths & Weaknesses
Table 134. Imagen Technologies Basic Information, Manufacturing Base and Competitors
Table 135. Imagen Technologies Major Business
Table 136. Imagen Technologies Artificial Intelligence in Pharma and Biotech Product and Services
Table 137. Imagen Technologies Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Imagen Technologies Recent Developments/Updates
Table 139. Imagen Technologies Competitive Strengths & Weaknesses
Table 140. Vuno Inc. Basic Information, Manufacturing Base and Competitors
Table 141. Vuno Inc. Major Business
Table 142. Vuno Inc. Artificial Intelligence in Pharma and Biotech Product and Services
Table 143. Vuno Inc. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. Vuno Inc. Recent Developments/Updates
Table 145. Vuno Inc. Competitive Strengths & Weaknesses
Table 146. IDx Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table 147. IDx Technologies Inc. Major Business
Table 148. IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Product and Services
Table 149. IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 150. IDx Technologies Inc. Recent Developments/Updates
Table 151. IDx Technologies Inc. Competitive Strengths & Weaknesses
Table 152. Siemens Healthcare GmbH Basic Information, Manufacturing Base and Competitors
Table 153. Siemens Healthcare GmbH Major Business
Table 154. Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Product and Services
Table 155. Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 156. Siemens Healthcare GmbH Recent Developments/Updates
Table 157. Siemens Healthcare GmbH Competitive Strengths & Weaknesses
Table 158. Neural Analytics Basic Information, Manufacturing Base and Competitors
Table 159. Neural Analytics Major Business
Table 160. Neural Analytics Artificial Intelligence in Pharma and Biotech Product and Services
Table 161. Neural Analytics Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 162. Neural Analytics Recent Developments/Updates
Table 163. Neural Analytics Competitive Strengths & Weaknesses
Table 164. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 165. Insilico Medicine Major Business
Table 166. Insilico Medicine Artificial Intelligence in Pharma and Biotech Product and Services
Table 167. Insilico Medicine Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 168. Insilico Medicine Recent Developments/Updates
Table 169. Insilico Medicine Competitive Strengths & Weaknesses
Table 170. Global Key Players of Artificial Intelligence in Pharma and Biotech Upstream (Raw Materials)
Table 171. Global Artificial Intelligence in Pharma and Biotech Typical Customers
LIST OF FIGURES
Figure 1. Artificial Intelligence in Pharma and Biotech Picture
Figure 2. World Artificial Intelligence in Pharma and Biotech Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Artificial Intelligence in Pharma and Biotech Total Revenue (2021-2032) & (USD Million)
Figure 4. World Artificial Intelligence in Pharma and Biotech Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Artificial Intelligence in Pharma and Biotech Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032) & (USD Million)
Figure 13. Artificial Intelligence in Pharma and Biotech Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 16. World Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 18. China Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 23. India Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Artificial Intelligence in Pharma and Biotech by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Artificial Intelligence in Pharma and Biotech Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Artificial Intelligence in Pharma and Biotech Markets in 2025
Figure 27. United States VS China: Artificial Intelligence in Pharma and Biotech Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Artificial Intelligence in Pharma and Biotech Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Artificial Intelligence in Pharma and Biotech Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Type in 2025
Figure 31. AI Drug Discovery
Figure 32. Preclinical Research AI
Figure 33. Clinical Trial AI
Figure 34. Others
Figure 35. World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Type (2021-2032)
Figure 36. World Artificial Intelligence in Pharma and Biotech Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Figure 37. World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Technology in 2025
Figure 38. Machine Learning
Figure 39. Deep Learning
Figure 40. Generative AI
Figure 41. Computer Vision
Figure 42. Others
Figure 43. World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Technology (2021-2032)
Figure 44. World Artificial Intelligence in Pharma and Biotech Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 45. World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Application in 2025
Figure 46. Oncology
Figure 47. Neurology
Figure 48. Immunology
Figure 49. Rare Diseases
Figure 50. Infectious Diseases
Figure 51. Others
Figure 52. World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Application (2021-2032)
Figure 53. Artificial Intelligence in Pharma and Biotech Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Artificial Intelligence in Pharma and Biotech Picture
Figure 2. World Artificial Intelligence in Pharma and Biotech Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Artificial Intelligence in Pharma and Biotech Total Revenue (2021-2032) & (USD Million)
Figure 4. World Artificial Intelligence in Pharma and Biotech Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Artificial Intelligence in Pharma and Biotech Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Artificial Intelligence in Pharma and Biotech Revenue (2021-2032) & (USD Million)
Figure 13. Artificial Intelligence in Pharma and Biotech Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 16. World Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 18. China Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 23. India Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Artificial Intelligence in Pharma and Biotech by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Artificial Intelligence in Pharma and Biotech Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Artificial Intelligence in Pharma and Biotech Markets in 2025
Figure 27. United States VS China: Artificial Intelligence in Pharma and Biotech Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Artificial Intelligence in Pharma and Biotech Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Artificial Intelligence in Pharma and Biotech Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Type in 2025
Figure 31. AI Drug Discovery
Figure 32. Preclinical Research AI
Figure 33. Clinical Trial AI
Figure 34. Others
Figure 35. World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Type (2021-2032)
Figure 36. World Artificial Intelligence in Pharma and Biotech Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Figure 37. World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Technology in 2025
Figure 38. Machine Learning
Figure 39. Deep Learning
Figure 40. Generative AI
Figure 41. Computer Vision
Figure 42. Others
Figure 43. World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Technology (2021-2032)
Figure 44. World Artificial Intelligence in Pharma and Biotech Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 45. World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Application in 2025
Figure 46. Oncology
Figure 47. Neurology
Figure 48. Immunology
Figure 49. Rare Diseases
Figure 50. Infectious Diseases
Figure 51. Others
Figure 52. World Artificial Intelligence in Pharma and Biotech Market Size Market Share by Application (2021-2032)
Figure 53. Artificial Intelligence in Pharma and Biotech Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
